These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6595216)

  • 1. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation.
    Hagner G
    Immunobiology; 1984 Oct; 167(4):389-97. PubMed ID: 6595216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific triggering of gamma, delta T cells by K562 activates the gamma, delta T cell receptor and may regulate natural killer-like function.
    Di Fabrizio L; Kimura Y; Ware R; Rogozinski L; Chess L
    J Immunol; 1991 Apr; 146(8):2495-503. PubMed ID: 1707908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of thymidine and dexamethasone increases the K562 tumor cells sensitivity to human leukocytes cytotoxicity].
    Anisimov AG; Chekmasova AA; Volkova TO; Nemova NN
    Tsitologiia; 2001; 43(1):76-81. PubMed ID: 11392818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the K562 cell sensitivity to nonspecific lysis by human and rat leukocytes under the influence of sodium butyrate, dimethyl sulfoxide and phorbol-12-myristate-13-acetate].
    Anisimov AG; Bolotnikov IA; Volkova TO
    Ontogenez; 2000; 31(1):47-52. PubMed ID: 10732363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
    Yanovich S; Hall RE; Weinert C
    Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer.
    Benoist H; Comoe L; Joly P; Carpentier Y; Desplaces A; Dufer J
    Cancer Immunol Immunother; 1989; 30(5):289-94. PubMed ID: 2624922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic action of natural killer cells on human tumor cells].
    Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
    Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of natural killer cell-mediated cytotoxicity by lipids extracted from Mycobacterium bovis BCG.
    Roozemond RC; Halperin M; Das PK
    Clin Exp Immunol; 1985 Dec; 62(3):482-90. PubMed ID: 3910316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cell-mediated cytotoxicity: a micro assay suitable for clinical tests.
    Tentori L; Alvino E; Fuggetta MP; D'Atri S; Giganti MG; Caliendo R; Bonmassar E
    Chemioterapia; 1985 Dec; 4(6):471-4. PubMed ID: 3868428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
    J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU; Golub SH
    J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.